Safety evaluation and toxicology studies and related services for drug development

Ended Awarded Last action

Contract number
75N95024D00022
Awardee
Awarding agency
Task orders
1 $1,000 obligated

Award facts

Opportunity
Combined order value
$1,000 Current and potential, with all options
Last date to order 100% complete
IDV ceiling <1% used
$48,622,546.00
Maximum order
$48,622,546.00
Award type
Multiple award
Who can order
Only the awarding agency
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 6 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $48.6 million multiple-award indefinite delivery contract to conduct safety evaluation and toxicology studies in support of drug development. The contract has a 6-year ordering period and allows NCATS to issue task orders for in vitro and in vivo safety testing services, including genetic toxicology, general toxicology, and pharmacology studies. The prime contractor, Mriglobal, is a 501(c)(3) not-for-profit research organization that specializes in areas such as medical countermeasure development, biosafety testing, and infectious disease research. Through this contract, Mriglobal will support NCATS' Division of Preclinical Innovation in advancing new and repurposed therapeutic candidates, including small molecules and biologics, through the preclinical development pipeline and towards regulatory submissions. The contract was awarded under full and open competition without any set-asides.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00003 $0
Terminate for Convenience P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N95024D00022?

75N95024D00022 was awarded to Mriglobal by National Institute on Drug Abuse (National Institutes of Health) on June 20, 2024.

How much is contract 75N95024D00022 worth?

Orders under 75N95024D00022 have obligated $1,000. 75N95024D00022's own ceiling is $48,622,546. A single order can be worth up to $48,622,546.

How many orders have been placed under contract 75N95024D00022?

1 order has been placed under 75N95024D00022, the latest on June 24, 2024.

Which agency awarded contract 75N95024D00022?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024D00022, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Who can order from contract 75N95024D00022?

75N95024D00022 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75N95024D00022 part of a contract vehicle?

Yes. 75N95024D00022 is part of Safety Evaluation and Toxicology Studies and Related Services for Drug Development.

Was contract 75N95024D00022 competed?

The extent of competition for 75N95024D00022 was full and open competition. The government received 6 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV